Produktinformation
IRAK inhibitor 6 is a kinase inhibitor that has been shown to be effective in both pre-clinical and clinical trials for cancer therapy. IRAK inhibitor 6 inhibits the activity of protein kinases, which are enzymes that regulate protein synthesis. This inhibition prevents the phosphorylation of proteins, which is required for their function. The inhibition of protein kinases by IRAK inhibitor 6 results in a decrease in cancer-related genes and an increase in normalizing proteins. In pre-clinical trials, this drug was shown to exhibit low toxicity and significant efficacy against cancers such as prostate cancer, colon cancer, and pancreatic cancer. In clinical trials, it was found to be safe at doses that were up to 10 times higher than the effective dose.
Chemische Eigenschaften
Technische Anfrage zu: 3D-SRB67297 IRAK inhibitor 6
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
